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Gregory L. Moneta, MD, Section EditorDiagnosis and Surgical Treatment of Nutcracker Syndrome: A Single-
Center Experience
Wang L, Yang L, Lui Z, et al. Urology 2009;73:871-6.
Conclusion: Left renal vein transposition is an efficient surgical treat-
ment for nutcracker syndrome. In some cases however pelvic pain remains
following left renal vein transposition.
Summary: The nutcracker syndrome is an unusual problem where
the left renal vein is narrowed as it passes between an angle formed
between the abdominal aorta and the superior mesenteric artery. This
narrowing of the left renal vein can lead to increase venous pressure
within the renal circulation and promote development of varices of the
renal pelvis and ureter with resulting hematuria. Other symptoms asso-
ciated with nutcracker syndrome include orthostatic proteinuria, flank
pain, left-sided varicocele, pelvic congestion, and chronic fatigue. The
authors retrospectively reviewed 23 patients with the diagnosis of nut-
cracker syndrome treated at their institution from July 1998 to July
2007. Nutcracker syndrome was suspected based on the combination of
clinical examination, ultrasound, CT imaging, and MRI imaging. Hema-
turia was the most common presenting symptom (21 of 23 patients). One
patient presented with orthostatic proteinuria and 1 with pelvic conges-
tion syndrome. No patient had renal function deterioration and 13 of 23
undergoing cystoscopy had bleeding noted from the left ureteral orifice.
Only 7 underwent transposition of the left renal vein with the indication
of transposition being recurrent gross hematuria in 6 patients and
persistent orthostatic proteinuria in 1 patient. Sixteen patients who had
more mild symptoms were followed without operation. Patients with
microscopic hematuria or intermittent short periods of painless gross
hematuria were followed closely without treatment. Patients with flank
or abdominal pain were treated with low-dose aspirin treatment. Four
women with pelvic congestion syndrome were treated with medroxypro-
gesterone acetate.
Patients undergoing left renal vein transposition did so through a
mid-line abdominal incision with mobilization of the left colon and small
bowel to give access to the retroperitoneum. The inferior adrenal vein,
ovarian/testicular vein, and the lumbar vein draining into the left renal vein
were ligated and transected. The left renal vein was excised with the small rim
of vena cava and injected with heparin. Reanastomosis was then performed
to a more caudad portion of the inferior vena cava. All 7 patients treated with
renal vein transposition had normal pre-operative creatinine levels with no
increase following renal vein transposition. Hematuria and proteinuria
ceased spontaneously 5 to 14 days following surgery with no clinical relapses.
Of the 16 patients treated conservatively, clinical improvement occurred in
11 with total relief of symptoms in 2 patients and partial relief in 9 patients.
There was no relief of symptoms in 5 patients following a mean follow-up of
41.2 months.
Comment: The pressure gradient between the left renal vein near the
renal hilum is normally between 0 and 1 mmHg (J Urology 1982; 127:
1070-1071). An elevated gradient of more than 3 mmHg between the left
renal vein and the vena cava is used as a criteria to diagnose nutcracker
syndrome. All patients in this series had such a gradient. The study indicates
that left renal vein transposition works well to alleviate symptoms in patients
with nutcracker syndrome and elevated renal vein IVC pressure gradients.
Equally important is that patients with mild symptoms do well treated
conservatively. It would appear reasonable to reserve surgical treatment of
nutcracker syndrome to those patients with recurrent gross hematuria or
persistent orthostatic proteinuria who are not responsive to conservative
management. The authors also point out that children and adolescents can
have nutcracker syndrome that will frequently resolve as the child matures
into adulthood. Surgical treatment of nutcracker syndrome in children and
adolescents therefore, in most cases, should be avoided.
Endovascular Treatment of Type B Aortic Dissection: The Challenge of
Late Success
Rodrigues Alves CM, Palma da Fonseca JH, Marcondes de Souza JA, et al.
Ann Thorac Surg 2009;87:1360-5.
Conclusions: Following endovascular thoracic aortic repair, patients
with both acute and chronic type B aortic dissections have excellent initial
results. Frequent need for new interventions leads to a steady decline in
event-free survival rates, but overall survival curves are comparable in pa-
tients with type B dissection undergoing less complex surgical or medical
treatment.Summary: There is a trend towards liberalization of the use of TEVAR
for treatment of type B aortic dissection. From 1997-2004 the authors
1526treated 106 patients with complicated or symptomatic type B aortic dissec-
tion with thoracic endografts. In the 106 patients treated technical success
was obtained in 105, and clinical success in 88 (83%). The left subclavian
artery was covered in 24 cases. Two required subsequent elective left upper
extremity revascularization. Six patients required surgical conversion within
3 days. Five patients died within 30 days (4.7%), 2 from complications of
surgical conversion, 2 from rupture (1 rupture was in a patient with technical
success of TEVAR placement), and 1 died after an extensive CVA. Patients
treated for urgent conditions had a higher in-hospital mortality than those
treated for chronic conditions (18.7% vs. 2.2%, p0.02). There were 3
strokes, 1 case of paraplegia, and 1 case of paraparesis. Three patients had
peripheral vascular complications and there were 4 cases of acute renal
failure.
There were 84 patients discharged from the hospital with clinical
success and follow-up was obtained in 73. Average duration of follow-up in
these 73 patients was 35.9  28.5 months. In the 73 patients with late
follow-up, late failure of the TEVAR procedure was observed in 37%. There
were 8 late deaths due to aortic causes. There was only 1 patient with a type
A dissection that occurred late.
Comment: The most telling information here is the high rate of late
failure (37%). The Braile stent graft was implanted in this study. This graft is
not approved for use in the U.S. The explanation for late failure is unclear.
Some may be related to the type of graft implanted, the technique of graft
implantation (many patients early in this series were treated with only a short
graft if treated acutely), or it may relate to the fact that the aortic wall is
diffusely fragile in patients with aortic dissection. It is quite clear placement
of a thoracic stent graft in a patient with a type B aortic dissection, despite
good technical results, does not return the patient to a normal survival curve
or give them freedom from late aortic related complications. We are going to
need better data with more complete follow-up using FDA approved devices
to determine whether treatment of type B aortic dissection with TEVAR is
more than just a good idea and that it actually provides true clinical benefit.
Exposure to Low-Dose Ionizing Radiation from Medical Imaging
Procedures
Fazel R, Krumholz HM, Wang Y, et al. N Engl J Med 2009;361:849-57.
Conclusion: Medical imaging procedures are an important source of
exposure to ionizing radiation. They can result in high cumulative effective
doses of radiation.
Summary: Experimental and epidemiologic evidence link exposure to
low-dose ionizing radiation with the development of both leukemia and
solid cancers (National Research Council, Health Risks from Exposure to
Low-Levels of Ionizing Radiation Beir VII Phase 2 Washington D.C.
National Academics Press 2006). Individuals at risk for repeated radiation
exposure such as workers in the nuclear and healthcare industry are moni-
tored for radiation dose and restricted to effective dose of 0.1 mSv every 5
years with a maximum of 50 mSv allowed in any given year. There is,
however, little monitoring of cumulative radiation doses for those undergo-
ing medical imaging procedures. In this study, the authors analyze recent
data on the use of imaging from 5 healthcare markets across the United
States to estimate total effective dose of radiation from medical imaging
procedures. They identified 952,420 non-elderly adults (between 18-64
years of age) in the 5 healthcare markets between January 1, 2005 and
December 31, 2007. They used utilization data to estimate cumulative
effective doses of radiation for imaging procedures. Population-based rates
of exposure were calculated. The author’s defined annual effective radiation
dose as low when the dose was  3 mSv. Moderate-doses were defined as
between 3 and 20 mSv and high-doses as 20 to 50 mSv with very high-doses
50 mSv.
During the study period 68.8% of the identified adults (n655,613)
underwent at least 1 imaging procedure involving radiation exposure. Mean
cumulative effective radiation dose from imaging procedures was 2.46.0
mSv per enrollee per year. Moderate effective doses of radiation were
incurred in 193.8 enrollees per 1,000 per year whereas high and very-high
doses were incurred in 18.6 and 1.9 enrollees per 1,000 per year respectively.
Advancing age and female sex were associated with increased cumulative
effective doses of radiation. CT scanning and nuclear imaging accounted for
75.4% of cumulative effective doses and 81.8% of the total administrative
radiation dose was administered in an outpatient setting.
Comment: A CT angiogram of the chest results in an average effective
dose of 15 mSv while plain CTs of the chest, abdomen, or pelvis average
approximately 7 mSv. A single CTA of the abdomen and pelvis in apatient
with an aortic stent graft per year immediately places that patient into the
moderate annual effective dose of radiation. One additional CT scan will
